COVID-19News

Redcliffe Lifetech introduces Mucormycosis multiplex RT-PCR test

As a part of the diagnostic process, BAL samples will be used to directly detect the infection, with sample-to-result collection in less than 24 hours

Redcliffe Lifetech, a leading molecular diagnostics company, has introduced a non-invasive (Serum/Fluid) RT-PCR Test to detect the DNA of mucorales species. As a part of the diagnostic process, BAL samples will be used to directly detect the infection, with sample-to-result collection in less than 24 hours.

Redcliffe Lifetech through its innovative molecular diagnostic service will collect various samples for conducting RT-PCR Test such as Bronchoalveolar lavage (BAL) samples, Biopsy samples, paraffin-embedded, serum samples to detect the potential health disorder or diseases in people. The diagnosis of Mucormycosis will target Pan-Mucormycetes, Rhizopus spp., Mucor spp., Lichtheimis spp., Cunninghamella spp., Rhizomucor spp., Internal Control (IC).

Dheeraj Jain, Managing Director, Redcliffe Lifetech said, “We endeavour to assist the Government of India and the general public in combating this deadly infection with the most advanced approach. With the help of our technology, we can assist them in a timely diagnosis of Mucormycosis. This will undoubtedly aid in the diagnosis and treatment of patients.”

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close